Interleukin-15 contributes to the regulation of murine adipose tissue and human adipocytes

Obesity

Volumn 18, Issue 8, 2010, Pages 1601-1607

  Barra, Nicole G ^a   Reid, Sarah ^a   MacKenzie, Randy ^a   Werstuck, Geoff ^b   Trigatti, Bernardo L ^b   Richards, Carl ^a   Holloway, Alison C ^b   Ashkar, Ali A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE; INTERLEUKIN 15; RECOMBINANT PROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; APPETITE; ARTICLE; BLOOD; C57BL MOUSE; CALORIC INTAKE; FEMALE; HUMAN; IMMUNOLOGY; LIPID METABOLISM; METABOLISM; MOUSE; MOUSE MUTANT; NATURAL KILLER CELL; OBESITY; PHYSIOLOGY; WEIGHT GAIN; WEIGHT REDUCTION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; APPETITE; CYTOKINES; ENERGY INTAKE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-15; KILLER CELLS, NATURAL; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; OBESITY; RECOMBINANT PROTEINS; WEIGHT GAIN; WEIGHT LOSS;

MURINAE; MUS;

EID: 77955050747     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.445     Document Type: Article

References (26)

1. Popkin BM, Kim S, Rusev ER, Du S, Zizza C. Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes Rev 2006;7:271-293.
2. Fry J, Finley W. The prevalence and costs of obesity in the EU. Proc Nutr Soc 2005;64:359-362.
3. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
4. Kipping RR, Jago R, Lawlor DA. Obesity in children. Part 1: Epidemiology, measurement, risk factors, and screening. BMJ 2008;337:a1824.
5. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-79.
6. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008;29:2959-2971.
7. Juge-Aubry CE, Somm E, Giusti V et al. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 2003;52:1104-1110.
8. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-2282.
9. YE J. Regulation of PPARγ function by TNF-α. Biochem Biophys Res Commun 2008;374:405-408.
10. Netea MG, Joosten LA, Lewis E et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity, and insulin resistance. Nat med 2006;12: 650-656.
11. Grabstein KH, Eisenman J, Shanebeck K et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994;264:965-968.
12. Carson WE, Giri JG, Lindemann MJ et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994;180:1395-1403.
13. Carbó N, López-Soriano J, Costelli P et al. Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim Biophys Acta 2001;1526:17-24.
14. Pistilli EE, Siu PM, Alway SE. Interleukin-15 responses to aging and unloading-induced skeletal muscle atrophy. Am J Physiol, Cell Physiol 2007;292:C1298-C1304.
15. Alvarez B, Carbó N, López-Soriano J et al. Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue. Biochim Biophys Acta 2002;1570: 33-37.
16. Quinn LS, Strait-Bodey L, Anderson BG, Argilés JM, Havel PJ. Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway. Cell Biol Int 2005;29:449-457.
17. Almendro V, Fuster G, Busquets S et al. Effects of IL-15 on rat brown adipose tissue: uncoupling proteins and PPARs. Obesity (Silver Spring) 2008;16:285-289.
18. Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 2003;27 Suppl 3:S53-S55.
19. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008;57:3239-3246.
20. Almendro V, Carbó N, Busquets S et al. Interleukin-15 decreases lipid intestinal absorption. Int J Mol Med 2005;15:963-967.
21. Spalding KL, Arner E, Westermark PO et al. Dynamics of fat cell turnover in humans. Nature 2008;453:783-787.
22. Caspar-Bauguil S, Cousin B, Galinier A et al. Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett 2005; 579:3487-3492.
23. Nielsen AR, Hojman P, Erikstrup C et al. Association between IL-15 and obesity: interleukin-15 as a potential regulator of fat mass. J Clin Endocrin Metab 2008;93:4486-4493.
24. Wolin KY, Colditz GA. Can weight loss prevent cancer? Br J Cancer 2008;99:995-999.
25. Martí A, Marcos A, Martínez JA. Obesity and immune function relationships. Obes Rev 2001;2:131-140.
26. Dunne J, Lynch S, O'Farrelly C et al. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J Immunol 2001;167:3129-3138.